SuperGen Reports 2006 Third Quarter Financial Results
SuperGen Reports 2006 Third Quarter Financial Results
This author has not written his bio yet.
But we are proud to say that webadmin contributed 640 entries already.
SuperGen Reports 2006 Third Quarter Financial Results
SuperGen COO to Leave Company at Year-End
Astex Therapeutics initiates clinical trial with investigational anti-cancer drug AT9283
Mayne Pharma’s Purchase of SuperGen’s North American Oncology Products Completes
New anti-cancer drug discovery alliance between GlaxoSmithKline, the Wellcome Trust and The Institute of Cancer Research, focused on B-RAF inhibitors, builds on partnership between Astex, the Wellcome Trust, the Institute of Cancer Research and Cancer Res
SuperGen Reports 2006 Second Quarter Financial Results
SuperGen Announces Attainment of Milestone from the MGI PHARMA / Cilag GmbH, a Johnson & Johnson Company, Licensing for Dacogen(TM) (Decitabine) for Injection
Mayne Acquires SuperGen’s North American Oncology Products
SuperGen Completes Contract to Transition Wyeth Distribution of Nipent® Outside of the U.S.
SuperGen Receives U.S. Patent For Nipent® (Pentostatin For Injection)